Sector of the day · Scheduled
Health & Biotech
Health & Biotech companies raised $20.9B in equity in 2025–2026, 3.1% of all tracked capital, and 2026 has already passed 2025 ($12.6B against $8.4B).
Top raisers equity in 2025–2026, log scale
Isomorphic Labs leads with $2.7B, 13% of the sector's equity in 2025–2026.
Biggest rounds log scale
The biggest single round was Isomorphic Labs' $2.1B Series B on 12 May 2026, led by Thrive Capital.
Where the money went by stage equity in 2025–2026
Series C to E rounds took 34% of the equity; the median round there was $287M.
Most active investors companies backed in 2025–2026
T. Rowe Price backed 8 Health companies in 2025–2026. For RA Capital Management the sector is 100% of its tracked portfolio.
Investor groups that repeat here all sourced rounds in the sector
ARCH Venture Partners and T. Rowe Price invested together in 5 Health rounds, across Kardigan, Mirador Therapeutics, Ollin Biosciences and 1 other.
- ARCH Venture PartnersT. Rowe Price
- FidelityT. Rowe Price
- Kleiner PerkinsThrive Capital
- Sequoia CapitalThrive Capital
- GVThrive Capital
Where it happens equity in 2025–2026 by city
London is home to 2 of the 40 companies and 15% of the equity.
Notes and sources
- Totals count primary equity only. Health & Biotech ranks #8 of 12 sectors by equity raised in 2025–2026.
- 2026 runs to 15 Nov 2026, so the year comparison is not like for like.
- Investor groups: two or more shared rounds across two or more companies in the sector, over every sourced round.
- Data as of 15 Nov 2026. See the methodology.